Published on
February 23, 2021
- 15:43 GMT
C2 PHARMA Completes Regulatory Filings, Expands Portfolio to Solidify Position as a Leading Ophthalmic API Supplier
GRAND DUCHY OF LUXEMBOURG, LUXEMBOURG, February 23, 2021 /EINPresswire.com/ -- C2 PHARMA, a pharmaceutical group established in 2014 focused on niche active pharmaceutical ingredient (APIs), has expanded its portfolio of APIs and botanical extracts …
Distribution channels:
Chemical Industry, Healthcare & Pharmaceuticals Industry
...
